Biomarin Pharmaceutical Inc (BMRN)
65.69
+0.69
(+1.06%)
USD |
NASDAQ |
Dec 20, 16:00
65.65
-0.04
(-0.06%)
After-Hours: 20:00
Biomarin Pharmaceutical Total Liabilities (Quarterly): 1.438B for Sept. 30, 2024
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Merck & Co Inc | 72.97B |
| Biogen Inc | 11.95B |
| Pfizer Inc | 126.92B |
| Bristol-Myers Squibb Co | 76.47B |
| Moderna Inc | 3.876B |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 6.851B |
| Shareholders Equity (Quarterly) | 5.413B |
| Debt to Equity Ratio | 0.1098 |
| Current Ratio | 4.271 |
| Net Debt Paydown Yield | 0.73% |